Dual Chamber Injection Devices Market, 2024

As biological drugs continue to grow in terms of therapeutics and total prescriptions, the impact of these specialty devices will increase, reaching a therapeutic market value of $5.3 billion annually in 2024.

The need to reconstitute lyophilized drugs at the point of administration and the potential safety and compliance issues this represents for patients has led to increasing interest in injection devices that can eliminate the number of steps required to reconstitute the drug and make it available for injection.

Dual chamber syringes and injectors - devices that allow reconstitution to take place within the device immediately prior to injection - represent the most elegant engineering solution to this need. While the use of dual chamber devices represents a cost premium for drug marketers relative to competing reconstitution methods such as vial adaptors, it also provides an opportunity for branding.

In terms of market penetration, dual chamber injection devices can be found in seven distinct therapeutic segments. We expect this number to grow as the influence of injectable biologicals on therapeutic practice increases.

What You Will Learn

Who Should Read this Report

Development

Industry

Market

Key Topics Covered:

1. Executive Summary

2. The Dual Chamber Injection Device Analysis

3. Dual Chamber Therapeutic Segments - Market Data & Forecasts

4. Market Factors

5 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/8f52zz/dual_chamber?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716